19 diciembre 2014
A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis, according to a new study. Eosinophilic esophagitis is a chronic immune system disease caused by a buildup of white blood cells in the lining of the esophagus. This build up, which is a reaction to food, allergens or acid reflux, can inflame or injure esophageal tissue.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/D3CKKUrE000/141219104041.htm
